Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Merck KGaA - SIC # 2821 - PLASTICS MATERIALS, SYNTHETIC RESINS, AND NONVULCANIZABLE ELASTOM
Ticker
Exchange
SIC #
Website
Latest Ticker
MKKGY
Over the counter
2821
www.merckgroup.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Merck KGaA
Merck KGaA, Darmstadt, Germany Signs Definitive Agreement to Acquire Rapid Micro Biosystems, Advancing Automation in Pharmaceutical Quality Control
- Nov 16th, 2026 7:57 am
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
- Nov 16th, 2026 7:28 am
Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
- Nov 16th, 2026 7:26 am
Sterile Filtration - Global Strategic Business Report: Secure Share of the $10.1 Billion 2030 Market as 3M, Merck KGaA, Parker Hannifin and Pentair Capitalize on 7.1% CAGR
- Nov 13th, 2026 8:08 am
Merck KGaA (XTRA:MRK) Stock Looks About Right On FDA Approval News
- Nov 13th, 2026 5:17 am
Merck KGaA (MKGAF) Q3 2026 Earnings Call Highlights: Third Guidance Raise Backed by Electronics ...
- Nov 12th, 2026 4:08 pm
What Merck KGaA (MRK) Said on Its Q3 Earnings Call
- Nov 12th, 2026 9:15 am
Silence Therapeutics Highlights Recent Business Achievements and Reports Third Quarter 2026 Financial Results
- Nov 12th, 2026 6:00 am
Merck KGaA (MKKGY) Lags Q3 Earnings Estimates
- Nov 12th, 2026 4:10 am
Merck shares hit over 1-year high as Q3 beats estimates and outlook is raised
- Nov 11th, 2026 11:59 pm
TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
- Nov 9th, 2026 5:50 am
Lonza (SWX:LONN) Stock Could Be 15% Overvalued On Its US CDMO Deal
- Nov 6th, 2026 1:17 pm
Protein Labeling - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $5.1 Billion by 2032 as Thermo Fisher Scientific, Merck KgaA, Promega, and Roche Reshape Protein Research
- Nov 5th, 2026 8:29 am
Earnings Preview: Merck KGaA (MKKGY) Q3 Earnings Expected to Decline
- Nov 5th, 2026 7:00 am
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates
- Nov 5th, 2026 6:35 am
Bio-Techne (TECH), What Is Behind The Fresh Attention Now?
- Nov 4th, 2026 12:10 pm
CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index
- Nov 4th, 2026 10:00 am
Merck KGaA, Darmstadt, Germany Hosts Change Chemistry European Forum To Advance Safety and Sustainability in Chemistry
- Nov 4th, 2026 9:00 am
Cell Based Assays - Global Strategic Business Report 2026: Capitalize on the $30.5B Market by 2032 as Thermo Fisher, Danaher, Merck KGaA and Lonza Accelerate AI, 3D Cultures and Automation
- Nov 4th, 2026 8:17 am
Scroll